AUTHOREA
Log in Sign Up Browse Preprints

loading page

Oncolytic effect of SARS-CoV-2 in a patient with mycosis fungoides (MF): a case report
  • +1
  • Laya Ohadi,
  • Fatemeh Hosseinzadeh,
  • Sahar Dadkhahfar,
  • Soheila Nasiri
Laya Ohadi
Shahid Beheshti University of Medical Sciences

Corresponding Author:[email protected]

Author Profile
Fatemeh Hosseinzadeh
Shahid Beheshti University of Medical Sciences
Author Profile
Sahar Dadkhahfar
Shahid Beheshti University of Medical Sciences
Author Profile
Soheila Nasiri
Skin Research Center Shahid Beheshti University of Medical Sciences
Author Profile

Abstract

The most common variant of cutaneous T-cell lymphomas (CTCL) is mycosis fungoides (MF).The spontaneous regression (SR) of MF is rare. Here, we are reporting an interesting case of refractory MF after COVID-19. The SARS-CoV-2 could be an essential component in the improvement of clinical features related to MF.

Peer review status:Published

08 Jan 2022Submitted to Clinical Case Reports
Show details
Hide details
11 Jan 2022Submission Checks Completed
11 Jan 2022Assigned to Editor
13 Jan 2022Reviewer(s) Assigned
16 Jan 2022Review(s) Completed, Editorial Evaluation Pending
24 Jan 2022Editorial Decision: Revise Minor
06 Mar 20221st Revision Received
07 Mar 2022Submission Checks Completed
07 Mar 2022Assigned to Editor
07 Mar 2022Review(s) Completed, Editorial Evaluation Pending
15 Mar 2022Editorial Decision: Accept
Apr 2022Published in Clinical Case Reports volume 10 issue 4. 10.1002/ccr3.5682